BGLAP and Alzheimer disease: Along with the bone-derived osteocalcin, the osteocyte-derived sclerostin may regulate the Wnt/β-catenin signaling pathway, which is essential for regulating bone metabolism and cognitive function and has been associated with Alzheimer’s disease progression (14, 32, 33).